Rapid Response: Riding the Ozempic wave, w/RO's CEO Zach Reitano
Masters of Scale
Navigating Weight Loss Medications and Stigma
This chapter delves into the complex dynamics of weight loss drugs like Ozempic and Wagovi, addressing the stigma surrounding obesity while emphasizing the importance of FDA-guided prescribing practices. It highlights the need for patient-centric marketing to confront societal shame tied to health issues and discusses the implications of insurance coverage on accessibility and affordability of these medications. Additionally, the conversation touches on future innovations in weight management and the expanding potential for improving cardiometabolic health.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
